News & Media
News and features
30 June 2008Tonabersat highlighted at AHS Symposium
Minster is pleased to announce that, Professor David W Dodick, MD Dept of Neurology, Mayo Clinic, Scottsdale, gave a presentation - Gap Junction Blockers: Targeting Migraine Prevention, at a satellite symposium at the AHS’s 50th Meeting
Read more
American Headache Society 50th Scientific Meeting
Minster is pleased to announce that a scientific paper on tonabersat, will be the subject of a presentation today at the 50th Annual Scientific Meeting of the American Headache Society (AHS).
Read more
Grant of Share Options to Directors
Read more
Annual General Meeting
Read more
Result of Annual General Meeting
Read more
Minster Pharmaceuticals plc (AIM: MPM), is pleased to announce that its Phase IIb TEMPUS study is now fully enrolled.
Read more
Annual Report and Financial Statements
Minster Pharmaceuticals Plc announces that it has posted to shareholders the Annual Report and Financial Statements for the year ended 31 March 2008,
Read more
Appointment of US development and marketing consultant
Preliminary Announcement of Audited Results for the year ended 31 March 2008
Annual Report and Financial Statement 2008
Phase II migraine with aura trial fully enrolled
Minster Pharmaceuticals is pleased to announce that its Phase II trial in Denmark of tonabersat in the prevention of migraine with aura is now fully enrolled.
Read more